School of Medicine


Showing 21-40 of 133 Results

  • Graham Creasey

    Graham Creasey

    Paralyzed Veterans of America Professor of Spinal Cord Injury Medicine, Emeritus

    Current Research and Scholarly InterestsNeural prostheses to stimulate and record from the peripheral and central nervous system, thereby directly connecting nervous systems with electronic systems

    Neural prostheses for control of bladder, bowel and sexual function after spinal cord injury

  • Atman Desai, MD

    Atman Desai, MD

    Clinical Associate Professor, Neurosurgery

    Current Research and Scholarly InterestsThe Stanford Spine Artificial Intelligence Laboratory, led by Dr. Atman Desai MD, MA, FACS, is a collaboration of Stanford neurosurgeons, radiologists, orthopedic surgeons and data scientists who share the goal of advancing the field of artificial intelligence to provide better surgical outcomes for spine patients. Our laboratory works closely with the Stanford Center for Artificial Intelligence in Medicine and Imaging, and studies the application of computer vision and deep learning to spinal i

  • Jun Ding

    Jun Ding

    Associate Professor of Neurosurgery and of Neurology

    Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders

  • Robert Dodd, MD, PhD

    Robert Dodd, MD, PhD

    Associate Professor of Neurosurgery, of Radiology and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)

    Current Research and Scholarly InterestsDr. Dodd is involved in clinical trials using endovascular coils that have a fiber coating that help heal aneurysms of the neck and can prevent an aneurysm from reforming. He uses minimally invasive endoscopic techniques to treat brain tumors.

    Dodd's research interests are in cerebral blood vessel reactivity and stroke.

  • Jordan Farrell

    Jordan Farrell

    Instructor, Neurosurgery
    Postdoctoral Scholar, Neurosurgery

    Current Research and Scholarly InterestsI aim to better understand hippocampal network function in both physiology and epilepsy using in vivo imaging, optogenetics, and electrophysiology.

  • Juan Carlos Fernandez-Miranda

    Juan Carlos Fernandez-Miranda

    Professor of Neurosurgery and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)

    BioDr. Juan Fernandez-Miranda is Professor of Neurosurgery and Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers. He is internationally renowned for his expertise in minimally invasive brain surgery, endoscopic skull base and pituitary surgery, open skull base surgery, and complex brain tumor surgery. He has performed nearly 3,000 cranial operations including over 1,500 endoscopic endonasal operations for pituitary tumors and other skull base lesions. He is highly regarded for his innovative contributions to the development and refinement of endoscopic endonasal skull base surgery, for his ability to select the most effective and less invasive approach to each individual patient, and for his precise knowledge of the intricate anatomy of the white matter tracts required to maximize resection and minimize morbidity on high and low grade glioma patients. He has been recently ranked by Expertscape as World-Expert (top 0.05%) on Skull Base Surgery and #1 Neurosurgeon Expert on Skull Base Tumors (pituitary adenomas, meningiomas, craniopharyngiomas, chordomas, chondrosarcomas, schwannomas and esthesioneuroblastomas) on the US Pacific Region. He is co-founder and vice-president of the International Rhoton Society and executive member of the Board of Directors of the The Neurosurgical Atlas, the largest nonprofit organization for neurosurgical education and research in the world.

    Dr. Fernandez-Miranda completed neurosurgery residency at La Paz University Hospital in Madrid, Spain. Upon completion of his residency, he was awarded the Sanitas Prize to the best medical postgraduate trainee in the country. From 2005 to 2007, he underwent fellowship training in microsurgical neuroanatomy at the University of Florida under legendary neurosurgeon Albert L. Rhoton, Jr. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at the University of Virginia, and endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). During his 10-year tenure at UPMC, he pioneered endoscopic endonasal approaches to highly complex pituitary and skull base tumors, developed a world-class complex brain surgery program, and led a premier training and research program on surgical neuroanatomy and skull base surgery.

    In 2018, he was recruited to bring to Stanford his unique technical expertise and to collaborate with world-renowned Stanford colleagues across multiple disciplines, leading the establishment of one of the most preeminent centers worldwide for comprehensive treatment of complex lesions in the brain, skull base, and pituitary regions. His top priority is to provide gentle, accurate, and safe surgery, in a team-based and compassionate approach to patient care.

  • Paul Graham Fisher, MD

    Paul Graham Fisher, MD

    Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health

    Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.

  • Robert Fisher, MD, PhD

    Robert Fisher, MD, PhD

    The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.

  • Paul George, MD, PhD

    Paul George, MD, PhD

    Assistant Professor of Neurology and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
    We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.

    BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
    The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.

    APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
    The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes.

  • Jamshid Ghajar

    Jamshid Ghajar

    Clinical Professor, Neurosurgery

    Current Research and Scholarly InterestsPrincipal Investigator,
    “Concussion Definition Consortium – An Evidence Based Project”. Department of Defense. There are over 40 definitions of concussion but none are evidence based- i.e. come from well done studies. We will extract the most salient data from well run studies that are designed to give us a "snapshot" of what concussion is.


    Principal Investigator,
    “Multi-Dimensional Model for Brain Trauma”. The goal is to develop a dynamic model for concussion, validate it on a retrospective dataset, and design a second study to validate it on a prospective dataset. Department of Defense.


    Principal Investigator,
    “EYE-TRAC Advance”. Testing 10,000 subjects with normal and post concussive eye tracking. Military and civilian athletes are included. Department of Defense.

    Principal Investigator,
    B-TEC (Brain Trauma Evidence-based Consortium). Combines Stanford B-TEC clinical trials coordinating center with the Brain Trauma Foundation's B-TEC evidence-based center to promote and coordinate an evidence-based approach to the spectrum of brain trauma from concussion to coma.

  • Carl Gold

    Carl Gold

    Clinical Associate Professor, Neurology & Neurological Sciences
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Gold is a board-certified general neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold has a particular clinical interest in the inpatient diagnosis of uncommon or rare neurological disorders. He directs quality improvement for the department of Neurology and is actively involved in projects to improve the experience of patients with neurological conditions at Stanford. His primary research interest focuses on enhancing the communication skills of neurology residents and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.

    For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html

    Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html

    Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html

  • Gerald Grant, MD, FACS

    Gerald Grant, MD, FACS

    Botha Chan Endowed Professor

    Current Research and Scholarly InterestsDr. Grant directs a Blood-brain Barrier Translational Laboratory focusing on enhancing drug delivery to brain tumors in children.

  • Seunggu J Han

    Seunggu J Han

    Clinical Associate Professor, Neurosurgery

    BioDr. Seunggu Jude Han is a Clinical Associate Professor in Neurological Surgery. He completed his undergraduate studies at University of California, Los Angeles, and received his medical degree from University of California, San Francisco (UCSF). Dr. Han completed his residency training in Neurosurgery at UCSF, as well as a fellowship in Neuro-Oncology at UCSF.

    Dr. Han joins Stanford from Oregon Health and Science University (OHSU), where he served as an assistant professor of Neurological Surgery, the Associate Program Director of the Neurosurgery residency training program, and Surgical Director of Neuro-Oncology at the Knight Cancer Institute.

    He remains passionate about underserved care and medical education. His clinical and academic interests include brain tumors, brain mapping, and quality improvement. Dr. Han has published over 100 peer-reviewed articles.